TFF Pharmaceuticals, Inc. Rings the Opening Bell

ABOUT THIS EVENT

TFF Pharmaceuticals, Inc. (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Glenn Mattes, President & CEO, rang the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore